Survanta
NDC 0074-1040, Beractant, suspension, from AbbVie Inc..
- Product NDC
- 0074-1040
- Status
- Listed
- Labeler
- AbbVie Inc.
- Dosage form
- SUSPENSION
- Route
- ENDOTRACHEAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA020032
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BERACTANT25 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0074-1040-04 | 00074104004 | 1 VIAL, SINGLE-USE in 1 CARTON (0074-1040-04) / 4 mL in 1 VIAL, SINGLE-USE |
| 0074-1040-08 | 00074104008 | 1 VIAL, SINGLE-USE in 1 CARTON (0074-1040-08) / 8 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7ef9e3a5-fc39-4ae1-0dad-6b47a1684635
Use it
Look up 0074-1040 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0074-1040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.